Analysis of cAMP RI alpha mRNA expression in breast cancer: evaluation of quantitative polymerase chain reaction for routine use.

por Bartlett, J. M., Hulme, M. J., Miller, W. R.
Publicado 1996

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer

por Edwards, J, Krishna, N S, Grigor, K M, Bartlett, J M S
Publicado 2003

The relationship between the systemic inflammatory response and survival in patients with transitional cell carcinoma of the urinary bladder

por Hilmy, M, Bartlett, J M S, Underwood, M A, McMillan, D C
Publicado 2005

Phosphorylation of the androgen receptor is associated with reduced survival in hormone-refractory prostate cancer patients

por McCall, P, Gemmell, L K, Mukherjee, R, Bartlett, J M S, Edwards, J
Publicado 2008

Tamoxifen resistance in early breast cancer: statistical modelling of tissue markers to improve risk prediction

por Baneshi, M R, Warner, P, Anderson, N, Edwards, J, Cooke, T G, Bartlett, J M S
Publicado 2010

Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer

por Tam, L, McGlynn, L M, Traynor, P, Mukherjee, R, Bartlett, J M S, Edwards, J
Publicado 2007

Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder?

por Bartlett, J. M., Watters, A. D., Ballantyne, S. A., Going, J. J., Grigor, K. M., Cooke, T. G.
Publicado 1998

Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder

por Edwards, J, Duncan, P, Going, J J, Grigor, K M, Watters, A D, Bartlett, J M S
Publicado 2001

HER2/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder

por Latif, Z, Watters, A D, Dunn, I, Grigor, K M, Underwood, M A, Bartlett, J M S
Publicado 2003

Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cells.

por Bartlett, J. M., Rabiasz, G. J., Scott, W. N., Langdon, S. P., Smyth, J. F., Miller, W. R.
Publicado 1992

Expression of transforming growth factor beta mRNA isoforms in human breast cancer.

por MacCallum, J., Bartlett, J. M., Thompson, A. M., Keen, J. C., Dixon, J. M., Miller, W. R.
Publicado 1994

Changes in expression of transforming growth factor beta mRNA isoforms in patients undergoing tamoxifen therapy.

por MacCallum, J., Keen, J. C., Bartlett, J. M., Thompson, A. M., Dixon, J. M., Miller, W. R.
Publicado 1996

PTK (protein tyrosine kinase)-6 and HER2 and 4, but not HER1 and 3 predict long-term survival in breast carcinomas

por Aubele, M, Auer, G, Walch, A K, Munro, A, Atkinson, M J, Braselmann, H, Fornander, T, Bartlett, J M S
Publicado 2007

The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic infiltration and COX-2 expression and survival in patients with transition...

por Hilmy, M, Campbell, R, Bartlett, J M S, McNicol, A-M, Underwood, M A, McMillan, D C
Publicado 2006

Genetic aberrations of c-myc and CCND1 in the development of invasive bladder cancer

por Watters, A D, Latif, Z, Forsyth, A, Dunn, I, Underwood, M A, Grigor, K M, Bartlett, J M S
Publicado 2002

Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer

por Murri, A M Al, Bartlett, J M S, Canney, P A, Doughty, J C, Wilson, C, McMillan, D C
Publicado 2006

Regulation and function of the extracellular matrix protein tenascin-C in ovarian cancer cell lines

por Wilson, K E, Bartlett, J M S, Miller, E P, Smyth, J F, Mullen, P, Miller, W R, Langdon, S P
Publicado 1999

A role for BRCA1 in sporadic breast cancer

por Fraser, J A, Reeves, J R, Stanton, P D, Black, D M, Going, J J, Cooke, T G, Bartlett, J M S
Publicado 2003

Prognostic value of protein tyrosine kinase 6 (PTK6) for long-term survival of breast cancer patients

por Aubele, M, Walch, A K, Ludyga, N, Braselmann, H, Atkinson, M J, Luber, B, Auer, G, Tapio, S, Cooke, T, Bartlett, J M S
Publicado 2008

Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells.

por Rabiasz, G. J., Langdon, S. P., Bartlett, J. M., Crew, A. J., Miller, E. P., Scott, W. N., Smyth, J. F., Miller, W. R.
Publicado 1992